Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in AVXL — Anavex Life Sciences Corp.

CIK 1109448 NASHVILLE, TN
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$378,917
+$25,253 QoQ
Shares Held
146,300
+27.0% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. AVXL ranks #183 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in AVXL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $378,917 146,300
2026-03-31 $353,664 115,200
2025-12-31 $410,112 115,200
2025-09-30 $1,025,280 115,200
2025-06-30 $1,062,144 115,200
2025-03-31 $988,416 115,200
2024-12-31 $1,237,248 115,200
2024-09-30 $612,531 107,840
2024-06-30 $510,113 120,880
2024-03-31 $409,236 80,400
2023-12-31 $819,652 88,040
2023-09-30 $543,912 83,040
2023-06-30 $728,448 89,600
2023-03-31 $767,872 89,600
2022-12-31 $829,696 89,600
2022-09-30 $924,672 89,600
2022-06-30 $896,896 89,600
2022-03-31 $1,102,976 89,600
2021-12-31 $1,550,196 89,400
2021-09-30 $1,604,730 89,400
2021-06-30 $2,043,684 89,400
2021-03-31 $275,080 18,400
2020-12-31 $305,640 56,600
2020-09-30 $257,530 56,600
2020-06-30 $278,472 56,600
2020-03-31 $91,035 28,900